Rankings
▼
Calendar
WGS Q4 2021 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena
WGS
GeneDx Holdings Corp.
$3B
Q4 2021 Earnings
Healthcare
Medical - Healthcare Information Services
Income Statement
Revenue
$58M
-9.6% YoY
Gross Profit
$9M
15.9% margin
Operating Income
-$116M
-200.7% margin
Net Income
-$40M
-69.9% margin
EPS (Diluted)
$-5.49
QoQ Revenue Growth
+33.9%
Cash Flow
Operating Cash Flow
-$52M
Free Cash Flow
-$57M
Stock-Based Comp.
$37M
Balance Sheet
Total Assets
$554M
Total Liabilities
$166M
Stockholders' Equity
$388M
Cash & Equivalents
$401M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$58M
$64M
-9.6%
Gross Profit
$9M
$415,000
+2116.6%
Operating Income
-$116M
-$125M
+7.2%
Net Income
-$40M
-$126M
+67.8%
← FY 2021
All Quarters
Q1 2022 →